Are Plaintiffs Allegedly Injured by Generic Drugs Down and Out? Perspectives (and Debate) from Brand-Name and Generic Manufacturers in the Post-Mensing World

Biden Administration Issues Rules Requiring Insurer Transparency on Drug Spending, Rebates and Fees: What Manufacturers Need to Know

In House Warrior with Daniel Kracov